[新型口服头孢菌素和喹诺酮类药物对从尿液标本中分离出的耐氨苄西林大肠杆菌的比较活性]
[Comparative activity of new oral cephalosporins and quinolones against Escherichia coli resistant to ampicillin isolated from urinary specimens].
作者信息
Gharbaoui K, Hardy B, Larose P, Thibault M
机构信息
Laboratoire de bactériologie et virologie, Hôpital René Dubos, Pontoise.
出版信息
Pathol Biol (Paris). 1990 May;38(5):358-61.
PMID:2164180
Abstract
The activity of eight antibiotics was studied against fifty Escherichia coli strains resistant to ampicilline from positive urine cultures. We compared the in vitro activity and the inhibitory power of urine. Three antimicrobial agents are the most active: pefloxacin, ofloxacin and cefotaxime. Then in activity order: pipemidic acid, cefixime, cefuroxime, amoxicilline-clavulanic acid and cefalotine.
摘要
研究了8种抗生素对50株来自尿培养阳性且对氨苄西林耐药的大肠杆菌菌株的活性。我们比较了它们在体外的活性以及尿液的抑制能力。三种抗菌剂活性最强：培氟沙星、氧氟沙星和头孢噻肟。然后按活性顺序排列为：吡哌酸、头孢克肟、头孢呋辛、阿莫西林-克拉维酸和头孢噻吩。
相似文献
1
2
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.培氟沙星与其他五种喹诺酮类药物对耐萘啶酸变形杆菌属细菌的体外活性比较。
Chemioterapia. 1988 Oct;7(5):287-91.
3
[E.coli from urinary tract infections and acute pyelonephritis of children: 1% of strains are resistant to a subset of third generation cephalosporins].[来自儿童尿路感染和急性肾盂肾炎的大肠杆菌：1%的菌株对第三代头孢菌素的一个子集耐药]
Pathol Biol (Paris). 2004 Oct;52(8):497-500. doi: 10.1016/j.patbio.2004.07.035.
4
5
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].[儿童尿路感染病原菌的耐药性概况]
Tunis Med. 2004 Mar;82(3):299-305.
6
Resistance to quinolones in pathogens causing urinary tract infections.引起尿路感染的病原体对喹诺酮类药物的耐药性。
J Commun Dis. 1997 Sep;29(3):263-7.
7
Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.从瑞士南部社区获得性尿路感染门诊儿童中分离出的大肠杆菌菌株的药敏性。
Clin Ther. 2008 Nov;30(11):2090-5. doi: 10.1016/j.clinthera.2008.11.002.
8
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.普卢利沙星对从尿路感染分离出的大肠杆菌的体外活性及普卢利沙星耐药的生物学代价。
Int J Antimicrob Agents. 2007 Jun;29(6):679-87. doi: 10.1016/j.ijantimicag.2007.01.009. Epub 2007 Mar 23.
9
10
[Studies of susceptibility to antibiotics in strains of E. coli isolated from urine in the years 1986-1990].[1986 - 1990年从尿液中分离出的大肠杆菌菌株对抗生素敏感性的研究]
Ann Univ Mariae Curie Sklodowska Med. 1992;47:127-31.
Zotero 插件